Explaining rapid growth in Canadian biotechnology firms - ARCHIVED
Articles and reports: 88-003-X20000035770
Description:
Given the high cost of R&D, adopting the correct strategies and mix of products is required for success for Canadian biotechnology firms. A recent survey examined the rapid growth of 30 companies. Fast-growing enterprises adopted a strategy of patenting their products, avoiding major production delays, targeting export markets, accessing venture capital, conducting key alliances, and planning the IPO.
Issue Number: 2000003
Main Product: Innovation Analysis Bulletin
Format | Release date | More information |
---|---|---|
October 6, 2000 |
Related information
Source (Surveys and statistical programs)
- Date modified: